Market Cap 2.99B
Revenue (ttm) 491.73M
Net Income (ttm) 163.89M
EPS (ttm) N/A
PE Ratio 9.64
Forward PE 10.30
Profit Margin 33.33%
Debt to Equity Ratio 0.00
Volume 1,221,600
Avg Vol 1,239,442
Day's Range N/A - N/A
Shares Out 122.91M
Stochastic %K 93%
Beta 0.72
Analysts Strong Sell
Price Target $34.50

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 420 3200
Address:
355 Alhambra Circle, Suite 801, Coral Gables, United States
jimbecker
jimbecker Feb. 3 at 3:05 PM
$CPRX Trying to break out of a cup with handle pattern.
1 · Reply
StillWaiting101
StillWaiting101 Feb. 2 at 8:09 PM
0 · Reply
111ggg
111ggg Feb. 2 at 4:19 PM
$CPRX six month high. Is that good?
0 · Reply
111ggg
111ggg Jan. 29 at 9:23 PM
$CPRX For what itvis worth, a 1 week cup was formed.
1 · Reply
ElissaL
ElissaL Jan. 29 at 8:09 PM
$CPRX Part 1: Regarding the two Motions in Limine that were filed by Catalyst, I suggest you do not give much attention to them. Although I can only see the titles of the two Motions because I do not pay for a PACER subscription, the titles are sufficient to show that the evidence Catalyst is seeking to not have admitted during the trial does not pertain directly to the substantive nature of the suit - the validity of the patents. It is common for a party to not want evidence to be used in a trial that is not built on a solid foundation of accuracy. So, evidence that has not been independently authenticated is suspect. It would be prudent not to let the decision by the judge on these two Motions cause you to believe the judge is leaning in any particular way - for or against Catalyst or Hetero in this lawsuit. The decision will strictly relate to what the law says about the admissibility of the evidence that Hertero wants to use, not to the underlying validity of the patents.
1 · Reply
111ggg
111ggg Jan. 29 at 3:16 PM
$CPRX just cannot get past 24-25.
0 · Reply
StillWaiting101
StillWaiting101 Jan. 28 at 10:37 PM
$CPRX the market has been voltile and crazy lately, but everytime I check here, we are just plucking away, holding strong
0 · Reply
toradio
toradio Jan. 28 at 8:10 PM
$CPRX 2 days in a row...not that i'm counting... red to green....makes me smile...
0 · Reply
toradio
toradio Jan. 27 at 8:45 PM
$CPRX gotta luv this red to green thingy goin on....8^}}
0 · Reply
Calinda
Calinda Jan. 23 at 8:34 PM
$CPRX FYI: No settlement today at the final pretrial/settlement hearing.
0 · Reply
Latest News on CPRX
Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:08 AM EDT - 8 months ago

Strong Inflows Make Catalyst Stock an Outlier


Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 26, 2025, 8:12 AM EDT - 11 months ago

Strong Revenue, Drug Performance Lift Catalyst Shares


Catalyst Remains a Big Money Favorite

Feb 7, 2025, 3:56 PM EST - 1 year ago

Catalyst Remains a Big Money Favorite


jimbecker
jimbecker Feb. 3 at 3:05 PM
$CPRX Trying to break out of a cup with handle pattern.
1 · Reply
StillWaiting101
StillWaiting101 Feb. 2 at 8:09 PM
0 · Reply
111ggg
111ggg Feb. 2 at 4:19 PM
$CPRX six month high. Is that good?
0 · Reply
111ggg
111ggg Jan. 29 at 9:23 PM
$CPRX For what itvis worth, a 1 week cup was formed.
1 · Reply
ElissaL
ElissaL Jan. 29 at 8:09 PM
$CPRX Part 1: Regarding the two Motions in Limine that were filed by Catalyst, I suggest you do not give much attention to them. Although I can only see the titles of the two Motions because I do not pay for a PACER subscription, the titles are sufficient to show that the evidence Catalyst is seeking to not have admitted during the trial does not pertain directly to the substantive nature of the suit - the validity of the patents. It is common for a party to not want evidence to be used in a trial that is not built on a solid foundation of accuracy. So, evidence that has not been independently authenticated is suspect. It would be prudent not to let the decision by the judge on these two Motions cause you to believe the judge is leaning in any particular way - for or against Catalyst or Hetero in this lawsuit. The decision will strictly relate to what the law says about the admissibility of the evidence that Hertero wants to use, not to the underlying validity of the patents.
1 · Reply
111ggg
111ggg Jan. 29 at 3:16 PM
$CPRX just cannot get past 24-25.
0 · Reply
StillWaiting101
StillWaiting101 Jan. 28 at 10:37 PM
$CPRX the market has been voltile and crazy lately, but everytime I check here, we are just plucking away, holding strong
0 · Reply
toradio
toradio Jan. 28 at 8:10 PM
$CPRX 2 days in a row...not that i'm counting... red to green....makes me smile...
0 · Reply
toradio
toradio Jan. 27 at 8:45 PM
$CPRX gotta luv this red to green thingy goin on....8^}}
0 · Reply
Calinda
Calinda Jan. 23 at 8:34 PM
$CPRX FYI: No settlement today at the final pretrial/settlement hearing.
0 · Reply
toradio
toradio Jan. 23 at 8:04 PM
$CPRX today Mr. Wall Street taketh away...
2 · Reply
111ggg
111ggg Jan. 23 at 2:56 PM
$CPRX Hanging in there TVTX making nice comeback. Still plenry left on that one. As 101 stated, CPRX could see 30 if 26 appears. ZVRA potential buyout this year. Current speck...AQST for 2027 action. They are likely to get CRL next week. If approved it takes off. Do your own research, particularily regarding AQST.
0 · Reply
Viking0919
Viking0919 Jan. 22 at 5:55 PM
0 · Reply
Sambo87
Sambo87 Jan. 22 at 2:00 PM
0 · Reply
111ggg
111ggg Jan. 21 at 7:37 PM
$CPRX We have seen this story before. Hope this time the ending changes and you finally see 26 again.
0 · Reply
Johnny_Lever
Johnny_Lever Jan. 21 at 5:45 PM
$CPRX Nice follow through this morning!
0 · Reply
StillWaiting101
StillWaiting101 Jan. 20 at 10:56 PM
$CPRX showing off a little today in a bad market, flexed its muscles a little as everything else waivered
2 · Reply
Johnny_Lever
Johnny_Lever Jan. 20 at 9:38 PM
$CPRX Updated chart shows today's close above TL resistance.
0 · Reply
Johnny_Lever
Johnny_Lever Jan. 20 at 4:56 PM
$CPRX Making another run to push past TL resistance.
0 · Reply
JackCampbell
JackCampbell Jan. 17 at 9:16 PM
$CPRX Campbell & CO increased its stake in Catalyst Pharmaceuticals by 124.7% in Q3 to 97,840 shares, a position worth about $1.93 million. FYI - it´s really not my co!
0 · Reply
toradio
toradio Jan. 16 at 8:20 PM
$CPRX staying in the bottom of the channel.... keep tightening the spring..... and soon , it will move up nicely.
0 · Reply
111ggg
111ggg Jan. 16 at 1:48 PM
$CPRX Bio selloff continues as chip stocks soar
0 · Reply